These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
195 related articles for article (PubMed ID: 38742949)
21. A Risk Model Developed based on Homologous Recombination Deficiency Genes for Evaluating the Drug Sensitivity and Prognostic Prediction of Lung Adenocarcinoma. Hong L; Li J; Shao W Curr Med Chem; 2024 Oct; ():. PubMed ID: 39354765 [TBL] [Abstract][Full Text] [Related]
22. Identification of prognosis-related genes in the tumor microenvironment of stomach adenocarcinoma by TCGA and GEO datasets. Ren N; Liang B; Li Y Biosci Rep; 2020 Oct; 40(10):. PubMed ID: 33015704 [TBL] [Abstract][Full Text] [Related]
23. Establishment of the molecular subtypes and a risk model for stomach adenocarcinoma based on genes related to reactive oxygen species. Li G; Ping M; Zhang W; Wang Y; Zhang Z; Su Z Heliyon; 2024 Mar; 10(5):e27079. PubMed ID: 38463816 [TBL] [Abstract][Full Text] [Related]
24. Unraveling the unfolded protein response signature: implications for tumor immune microenvironment heterogeneity and clinical prognosis in stomach cancer. Ouyang W; Liu Y; Huang H; Tan Y; Huang Z; Jia X; Yu Y; Yao H Aging (Albany NY); 2024 May; 16(9):7818-7844. PubMed ID: 38700505 [TBL] [Abstract][Full Text] [Related]
25. Identification of a 14-lncRNA Signature and Construction of a Prognostic Nomogram Predicting Overall Survival of Gastric Cancer. Nie K; Deng Z; Zheng Z; Wen Y; Pan J; Jiang X; Yan Y; Liu P; Liu F; Li P DNA Cell Biol; 2020 Sep; 39(9):1532-1544. PubMed ID: 32644844 [TBL] [Abstract][Full Text] [Related]
26. A novel gene signature related to fatty acid metabolism predicts prognosis, immune landscape, and drug sensitivity in early-stage lung squamous cell carcinoma. Xu J; Yu M; Fan W; Feng J Transl Cancer Res; 2024 Feb; 13(2):525-541. PubMed ID: 38482436 [TBL] [Abstract][Full Text] [Related]
27. Prognostic value of RNA methylation-related genes in gastric adenocarcinoma based on bioinformatics. He X; Chen X; Yang C; Wang W; Sun H; Wang J; Fu J; Dong H PeerJ; 2024; 12():e16951. PubMed ID: 38436027 [TBL] [Abstract][Full Text] [Related]
28. Identifying a Novel Defined Pyroptosis-Associated Long Noncoding RNA Signature Contributes to Predicting Prognosis and Tumor Microenvironment of Bladder Cancer. Lu H; Wu J; Liang L; Wang X; Cai H Front Immunol; 2022; 13():803355. PubMed ID: 35154117 [TBL] [Abstract][Full Text] [Related]
29. Identification of fatty acid metabolism-related molecular subtype biomarkers and their correlation with immune checkpoints in cutaneous melanoma. Xu Y; Chen Y; Jiang W; Yin X; Chen D; Chi Y; Wang Y; Zhang J; Zhang Q; Han Y Front Immunol; 2022; 13():967277. PubMed ID: 36466837 [TBL] [Abstract][Full Text] [Related]
30. Construction and Validation of a Novel Pyroptosis-Related Four-lncRNA Prognostic Signature Related to Gastric Cancer and Immune Infiltration. Wang Z; Cao L; Zhou S; Lyu J; Gao Y; Yang R Front Immunol; 2022; 13():854785. PubMed ID: 35392086 [TBL] [Abstract][Full Text] [Related]
31. A glycolysis-related signature to improve the current treatment and prognostic evaluation for breast cancer. Feng S; Ning L; Zhang H; Wang Z; Lu Y PeerJ; 2024; 12():e17861. PubMed ID: 39119106 [TBL] [Abstract][Full Text] [Related]
32. The prognostic and antitumor roles of key genes of ferroptosis in liver hepatocellular cancer and stomach adenocarcinoma. Pei W; Jiang M; Liu H; Song J; Hu J Cancer Biomark; 2024; 39(4):335-347. PubMed ID: 38393890 [TBL] [Abstract][Full Text] [Related]
33. Development and verification of a manganese metabolism- and immune-related genes signature for prediction of prognosis and immune landscape in gastric cancer. Han X; Leng C; Zhao S; Wang S; Chen S; Wang S; Zhang M; Li X; Lu Y; Wang B; Qi W Front Immunol; 2024; 15():1377472. PubMed ID: 38807601 [TBL] [Abstract][Full Text] [Related]
34. A novel microRNA signature predicts survival in stomach adenocarcinoma. Ding B; Gao X; Li H; Liu L; Hao X Oncotarget; 2017 Apr; 8(17):28144-28153. PubMed ID: 28423653 [TBL] [Abstract][Full Text] [Related]
35. Immune Landscape of Gastric Carcinoma Tumor Microenvironment Identifies a Peritoneal Relapse Relevant Immune Signature. Zhang C; Li D; Yu R; Li C; Song Y; Chen X; Fan Y; Liu Y; Qu X Front Immunol; 2021; 12():651033. PubMed ID: 34054812 [TBL] [Abstract][Full Text] [Related]
36. Novel lactylation-related signature to predict prognosis for pancreatic adenocarcinoma. Peng T; Sun F; Yang JC; Cai MH; Huai MX; Pan JX; Zhang FY; Xu LM World J Gastroenterol; 2024 May; 30(19):2575-2602. PubMed ID: 38817665 [TBL] [Abstract][Full Text] [Related]
37. Drug metabolism-related eight-gene signature can predict the prognosis of gastric adenocarcinoma. Yin HM; He Q; Chen J; Li Z; Yang W; Hu X J Clin Lab Anal; 2021 Dec; 35(12):e24085. PubMed ID: 34773716 [TBL] [Abstract][Full Text] [Related]
38. Identification of a 6-lncRNA prognostic signature based on microarray re-annotation in gastric cancer. Ma B; Li Y; Ren Y Cancer Med; 2020 Jan; 9(1):335-349. PubMed ID: 31743579 [TBL] [Abstract][Full Text] [Related]
39. Analysis and Validation of Tyrosine Metabolism-related Prognostic Features for Liver Hepatocellular Carcinoma Therapy. Cui Z; Liu C; Li H; Wang J; Li G Curr Med Chem; 2024 Feb; ():. PubMed ID: 38415454 [TBL] [Abstract][Full Text] [Related]
40. Cuproptosis-Related lncRNA Gene Signature Establishes a Prognostic Model of Gastric Adenocarcinoma and Evaluate the Effect of Antineoplastic Drugs. Tu H; Zhang Q; Xue L; Bao J Genes (Basel); 2022 Nov; 13(12):. PubMed ID: 36553481 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]